CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-08 | Saxonov Serge Chief Executive Officer | Sale | −5,239 | $186.91 | $979K | 906,429 |
| 2021-06-08 | Saxonov Serge Chief Executive Officer | Sale | −2,361 | $187.92 | $444K | 904,068 |
| 2021-06-08 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −5,209 | 84,573 | ||
| 2021-06-08 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −9,791 | 87,505 | ||
| 2021-06-04 | Saxonov Serge Chief Executive Officer | Gift | −200 | 904,068 | ||
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −1,597 | $171.58 | $274K | 411,894 |
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −703 | $172.56 | $121K | 411,191 |
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −600 | $173.72 | $104K | 410,591 |
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −1,500 | $174.80 | $262K | 409,091 |
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −2,400 | $175.77 | $422K | 406,691 |
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −100 | $176.72 | $18K | 406,591 |
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −300 | $178.21 | $53K | 406,291 |
| 2021-06-01 | STUELPNAGEL JOHN R Director | Sale | −300 | $179.78 | $54K | 405,991 |
| 2021-06-01 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 49,011 |
| 2021-06-01 | McAnear Justin J. Chief Financial Officer | Sale | −2,500 | $171.59 | $429K | 46,511 |
| 2021-06-01 | McAnear Justin J. Chief Financial Officer | Sale | −800 | $172.85 | $138K | 45,711 |
| 2021-06-01 | McAnear Justin J. Chief Financial Officer | Sale | −1,000 | $173.94 | $174K | 44,711 |
| 2021-06-01 | McAnear Justin J. Chief Financial Officer | Sale | −1,994 | $174.93 | $349K | 42,717 |
| 2021-06-01 | McAnear Justin J. Chief Financial Officer | Sale | −2,906 | $175.77 | $511K | 39,811 |
| 2021-06-01 | McAnear Justin J. Chief Financial Officer | Sale | −300 | $178.07 | $53K | 39,511 |
Page 35 of 57 · 1,128 trades